You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2025

Claims for Patent: 11,896,759


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,896,759
Title:Inhalers and related methods
Abstract:An inhaler (10) has a main body for accommodating a medicament reservoir (84), a canister fire system for moving a canister (50) to release a dose in response to air flow, a cap housing (12) for enclosing the canister fire system and canister within an interior chamber defined by the main body (14) and a cap housing, wherein a lock system (250) is provided for locking the cap housing on the main body.
Inventor(s):Daniel Buck, Paul Prendergast, Declan Walsh
Assignee: Norton Waterford Ltd
Application Number:US17/949,483
Patent Claims: 1. An inhaler for the inhalation of inhalable substances, the inhaler comprising: a main body and a cap housing defining an interior chamber; a canister enclosed within the interior chamber having an interior reservoir containing pressurised inhalable substances including fluid; a metering valve including a metering chamber and a valve stem defining a communication path between the metering chamber and the interior reservoir, the communication path including an first opening configured to permit flow between a transfer space inside the valve stem and the interior reservoir, the interior reservoir being arranged for orientation above the metering chamber whereby gas located within the metering chamber is replaced with liquid from the interior reservoir; and wherein a lock system is provided for locking the cap housing on the main body; the lock system including helical threads having non-overlapping and distinct thread segments for providing rotational attachment of the cap housing to the main body and a first lock member that cooperates with a second lock member to achieve a snap lock between the cap housing and the main body when the cap housing is rotationally attached to the main body in a locked position; wherein the thread segments are radially disposed about a central axis and arranged such that the thread segments are non-overlapping with respect to each other along the central axis; and wherein the first lock member is interposed between the thread segments.

2. The inhaler of claim 1, wherein the lock system is configured to resist relative longitudinal movement between the cap housing and the main body; and to resist rotation of the cap housing relative to the main body.

3. The inhaler of claim 1, wherein helical threads are provided for rotational attachment of the cap housing on the main body; and wherein the lock system includes a protrusion in a region of a helical thread on one of the main body and the cap housing which is lockable in a recess in a region of a helical thread on the other of the main body and the cap housing.

4. The inhaler of claim 1, in which the main body and the cap housing are formed of plastics material and the lock system is configured so that a release torque required to overcome the locking provided by the plastics main body and cap housing is more than 1 Nm.

5. The inhaler of claim 4, wherein the release torque required to overcome the locking provided by the plastics main body and cap housing is lower than 4 Nm.

6. The inhaler of claim 1, in which the lock system is configured such that a release torque is between 2 and 5 Nm.

7. The inhaler of claim 1, in which the communication path is configured to permit liquid to flow under pressure along the communication path to the metering chamber and gas to flow in a reverse direction therealong from the metering chamber into the interior reservoir.

8. The inhaler of claim 1, in which the first opening comprises an elongated opening.

9. The inhaler of claim 8, which includes a second opening or further openings into the communication path.

10. The inhaler of claim 9, in which the second opening is diametrically opposed to the first opening.

11. The inhaler of claim 1, in which the valve stem has at least one opening into the interior reservoir with an axially oriented portion facing directly axially along a longitudinal axis of the valve stem into the interior reservoir for the flow of fluid directly into the communication path in an axial direction along the valve stem.

12. The inhaler of claim 1, which includes a metering chamber exit port for venting the metering chamber to atmosphere via a stem block and/or nozzle.

13. The inhaler of claim 1, including a canister fire system enclosed in the interior chamber defined by the main body and the cap housing for ejecting inhalable substances from the inhaler in response to air flow by closing communication between the metering chamber and the interior reservoir and opening communication between the metering chamber and atmosphere.

14. The inhaler of claim 13, wherein the inhaler includes a drive for driving the canister relative to the valve stem.

15. The inhaler of claim 14, the drive including a drive spring.

16. The inhaler of claim 13, wherein the canister fire system is adapted to depress the valve stem into the canister to cause inhalable substances to be ejected from the inhaler and to hold the valve stem depressed with the metering chamber communicating with atmosphere.

17. The inhaler of claim 16, in which the canister fire system includes a reset actuator which is operable so as to extend the valve stem relative to the canister in order to close communication between atmosphere and the metering chamber and to open communication between the metering chamber and the interior reservoir.

18. The inhaler of claim 17, in which the reset actuator comprises a mouthpiece cap for a mouthpiece of the inhaler, the mouthpiece cap being closable to permit extension of the valve stem relative to the canister.

19. The inhaler of claim 18, which includes a preventer adapted, after an inhalation has taken place, to prevent a further inhalation until the mouthpiece cap has been closed to extend the valve stem.

20. The inhaler of claim 19, in which the preventer comprises a warning signaller comprising at least one of, an audible alarm, a visual alarm, a dose counter or a warning notice.

21. The inhaler of claim 1, wherein the inhaler includes an actuator system for operating a drive.

22. The inhaler of claim 21, in which the actuator system is actuable by air flow.

23. The inhaler of claim 1, wherein the inhalable substances comprise at least one propellant.

24. The inhaler of claim 1, which includes a dose counter for counting doses.

25. The inhaler of claim 24, wherein the dose counter is configured to count one count for each inhalation of a dose.

26. The inhaler of claim 24, in which the dose counter includes: (a) a tape bearing dose indicia for displaying counts and/or (b) an actuator pin for contact with the canister, or a body movable therewith, for counting doses, the actuator pin extending out of a dose counter chamber through an aperture in a wall for contact during counting with the canister.

27. The inhaler of claim 26, further comprising a barrier configured to separate a dose counter chamber from an inner space of the inhaler for containing the canister.

28. The inhaler of claim 27, wherein the inhaler is a nasal inhaler, and the barrier comprises a stepped barrier having a vertical surface and a horizontal surface and the dose counter is coupled to at least one of the vertical surface and the horizontal surface.

29. The inhaler of claim 1, wherein the inhaler is a breath actuated inhaler.

30. The inhaler of claim 1, wherein the inhaler is a metered dose inhaler.

31. The inhaler of claim 1, wherein the inhaler is an oral inhaler.

32. The inhaler of claim 1, wherein the inhaler is a nasal inhaler.

33. The inhaler of claim 1, which includes a reset actuator which when actuated prevents exposure of the metering chamber to atmosphere, wherein the inhaler provides 75 to 125% of labelled claim for a dose following exposure of the metering chamber to atmosphere for a time period which is more than one minute.

34. The inhaler of claim 33, in which the inhaler provides 75 to 125% of labelled claim for a dose following exposure of the metering chamber to atmosphere for a time period which is more than two minutes.

35. The inhaler of claim 33, in which the inhaler provides 75 to 125% of labelled claim for a dose following exposure of the metering chamber to atmosphere for a time period which is one hour, more than one hour, 24 hours or more than 24 hours.

36. The inhaler of claim 33, in which the reset actuator is a mouthpiece cap that, when closed, prevents exposure of the metering chamber to atmosphere.

37. The inhaler of claim 1, which includes a metering valve spring and an opposing canister spring for drivingly firing the canister, the metering valve spring, canister spring and metering valve being arranged in the inhaler such that an equilibrium of various forces is achieved in at least one ready-to-fire configuration of the inhaler.

38. The inhaler of claim 37, which is adapted to operate including at least one suction force.

39. The inhaler of claim 38, wherein the suction force operates against the canister spring.

40. The inhaler of claim 1, wherein the inhaler is a nasal inhaler and the nasal inhaler comprises a nosepiece cap coupled to the main body, the nosepiece cap moveable with respect to the main body from a closed position to an open position; and a yoke coupled to the main body and the canister, the yoke moveable from a first position to a second position as the nosepiece cap moves from the closed position to the open position, wherein the canister moves with respect to the main body as the yoke moves from the first position to the second position.

41. The inhaler of claim 40, wherein the nosepiece cap includes a cam and the yoke includes a leg engageable with the cam such that rotation of the nosepiece cap causes movement of the yoke.

42. The inhaler of claim 40, wherein the canister is moveable in a dispensing direction from a storage position to a dispensing position, and wherein the canister moves in the dispensing direction as the yoke moves with respect to the housing.

43. The inhaler of claim 1, in which the lock system is configured such that a release torque is lower than 4 Nm.

44. The inhaler of claim 1, in which the lock system is configured such that a release torque is between 2.5 and 3 Nm.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.